GOT2 is not only highly expressed in cancer cells but is also broadly expressed in immune cells (such as T cells and macrophages) and stromal cells (such as fibroblasts and endothelial cells) within the tumor microenvironment. The gene discussed is GOT2; the disease is cancer.